Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial-Reference-Cited by-同舟云学术

Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial

Published:2017-04 Issue:4 Volume:16 Page:291-300
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Zakrzewska Joanna M,Palmer Joanne,Morisset Valerie,Giblin Gerard MP,Obermann Mark,Ettlin Dominik A,Cruccu Giorgio,Bendtsen Lars,Estacion Mark,Derjean Dominique,Waxman Stephen G,Layton Gary,Gunn Kevin,Tate Simon

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference29 articles.

1. The International Classification of Headache Disorders, 3rd edn (beta version);Cephalalgia,2013

2. AAN-EFNS guidelines on trigeminal neuralgia management;Cruccu;Eur J Neurol,2008

3. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults;Wiffen;Cochrane Database Syst Rev,2014

4. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain;Di Stefano;J Headache Pain,2014

5. Comparison of tolerability and adverse symptoms in oxcarbazepine and carbamazepine in the treatment of trigeminal neuralgia and neuralgiform headaches using the Liverpool Adverse Events Profile (AEP);Besi;J Headache Pain,2015

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The PATCH trial: 5% lidocaine‐medicated plaster for trigeminal neuralgia—Results of a multicentric, enriched enrollment, randomized withdrawal, double‐blind, vehicle‐controlled, parallel‐group study;Headache: The Journal of Head and Face Pain;2024-08-28

2. An overview of the safety and efficacy of LX-9211 in treating neuropathic pain conditions;Expert Opinion on Investigational Drugs;2024-07-08

3. Nanomedicine and voltage-gated sodium channel blockers in pain management: a game changer or a lost cause?;Drug Delivery and Translational Research;2024-06-11

4. Pharmacotherapy and noninvasive neurostimulation for neuropathic pain;La Presse Médicale;2024-06

5. Trigeminal neuralgia;Nature Reviews Disease Primers;2024-05-30